BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Azaya Therapeutics, Inc. 

100 Sandau Drive
Suite 200
San Antonio  Texas  78216  U.S.A.
Phone: 210-341-6600 Fax: 210-341-6619


SEARCH JOBS




Industry
Healthcare

Segment
Biotechnology





 Company News
Azaya Therapeutics, Inc. Collaborates With University of Chicago In Combination Study In Animals 5/6/2014 10:21:12 AM
CANbridge Life Sciences Enters Into Agreement With Azaya Therapeutics, Inc. to Develop ATI-1123 for Lung Cancer in China and North Asia 9/11/2013 9:44:19 AM
Azaya Therapeutics, Inc. Launches Parexo Labs, Offering Liposomal Manufacture and Nanotechnology Testing Services to Drug and Device Developers 7/8/2013 10:22:44 AM
Azaya Therapeutics, Inc. Initiates Bioequivalency Study for Regulatory Approval of ATI-0918, a Liposomal Formulation of Doxorubicin Hydrochloride 10/24/2012 9:39:22 AM
Azaya Therapeutics, Inc. Reports Results of Phase I Clinical Trial 6/13/2012 10:05:23 AM
ResearchPoint & Azaya Therapeutics, Inc. Announce First Patient Enrolled in Phase I Clinical Study 1/26/2010 9:35:50 AM
SATAI Announces $1.045 Million Emerging Technology Fund Investment in Azaya Therapeutics, Inc. 9/30/2009 9:26:01 AM
Azaya Therapeutics, Inc. Initiates Collaboration With National Cancer Institute in Nanoparticle Characterization 3/10/2009 8:51:07 AM
Azaya Therapeutics, Inc. Licenses Promising Treatment for Head and Neck Cancers 9/3/2008 8:35:10 AM
Azaya Therapeutics, Inc. Elects Ze'ev Shaked, Ph.D., to Board of Directors 5/31/2007 5:20:04 PM
12